Sign in

CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 1235 430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Chief Financial Officer sold 96,000 shares at $0.01 ($950)
  3. 4 Open-market sale Chief Operating Officer sold 207,000 shares at $0.01 ($2,091)
  4. 4 Open-market sale Director sold 19,500,000 shares at an average $0.01 ($229,172)
  5. 4 Open-market sale 10% owner sold 64,052,538 shares at an average $0.11 ($6,890,236)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Chief Medical Officer sold 5,584 shares at $0.58 ($3,243)
  13. 4 Open-market sale Chief Patient Supply Officer sold 5,584 shares at $0.58 ($3,243)
  14. 4 Open-market sale Chief Operating Officer sold 5,584 shares at $0.58 ($3,243)
  15. 4 Open-market sale Chief Executive Officer sold 30,601 shares at $0.58 ($17,773)
  16. 4 Open-market sale Chief Executive Officer sold 59,569 shares at an average $0.58 ($34,639)
  17. 4 Open-market sale Chief Commercial Officer sold 12,991 shares at $0.57 ($7,467)
  18. 4 Open-market sale Chief Medical Officer sold 22,195 shares at an average $0.58 ($12,920)
  19. 4 Open-market sale Chief Patient Supply Officer sold 19,542 shares at an average $0.58 ($11,360)
  20. 4 Open-market sale Chief Operating Officer sold 19,542 shares at an average $0.58 ($11,360)

Page 1 of 18 · 351 filings